TESTOSTERONE DEFICIENCY AND NON-ALCOHOLIC FATTY LIVER DISEASE IN MEN WITH TYPE 2 DIABETES MELLITUS

被引:0
|
作者
Khripun, Irina A. [1 ]
Vorobyev, Sergey V. [1 ]
Allakhverdieva, Yanina S. [1 ]
机构
[1] Rostov State Med Univ, Rostov Na Donu, Russia
来源
DIABETES MELLITUS | 2019年 / 22卷 / 06期
关键词
hypogonadism; testosterone; diabetes mellitus; nonalcoholic fatty liver disease; liver; androgen deficiency; HYPOGONADISM;
D O I
10.14341/DM10232
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Current studies investigated diseases associated with testosterone (T) deficiency; however, data on the combination of non-alcoholic fatty liver disease (NAFLD) with hypogonadism and diabetes mellitus (DM) in men are extremely limited. AIMS: To evaluate the effects of hypogonadism on the formation and progression of NAFLD in men with type 2 DM. METHODS: The study included 90 men with type 2 DM [age 54 (49-57) years]. Patients underwent clinical examinations, biochemical analysis (alanine aminotransferase (ALT), aspartate aminotransferase, gamma-glutamyl transpeptidase (GGTP), fasting glucose, immunoreactive insulin, HOMA index, HbA(1c), lipid profile), immune enzyme analysis (luteinising hormone, total T, sex hormone binding globulin, resistin, adiponectin, leptin) and magnetic resonance imaging with liver fat fraction determination were performed. Patients were divided into two groups: 1-32 eugonadal patients and 2-58 men with newly diagnosed hypogonadism. RESULTS: Increased insulin resistance, hyperinsulinemia, hypertriglyceridemia were observed in men with hypogonadism compared to eugonadal patients. Along with biochemical signs of impaired liver function, such as an increase in liver enzyme concentrations of ALT by 24.5% (p = 0.02), GGTP by 60.5% (p = 0.001), de Rytis coefficient by 60.4% (p = 0.047), of men in the 2nd group, the liver fat fraction also increased, which together indicates NAFLD progression. The proton density of the liver fat fraction according to MRI was 4.12 [2.25-5.30] % in the 1st group and 10.30 [7.78; 14.44] % in the 2nd group (p=0.001). This was accompanied by an increase in fat production of resistin by 2 times and leptin by 12 times (p<0.001) in patients of group 2 compared to 1. CONCLUSIONS: The combination of type 2 DM with hypogonadism in men leads not only to deterioration of carbohydrate and lipid metabolism but also to disturbance of liver function: increased ALT, GGTP concentrations and liver fat. Increased secretion of leptin and resistin in the adipose tissue is assumed to be a pathogenetically associated with the development of carbohydrate and lipid metabolism disorders, NAFLD and T deficiency.
引用
收藏
页码:542 / 549
页数:8
相关论文
共 50 条
  • [21] Non-alcoholic fatty liver disease: A major challenge in type 2 diabetes mellitus (Review)
    Bica, Cristina
    Sandu, Camelia
    Suceveanu, Andra Iulia
    Sarbu, Eliza
    Stoica, Roxana Adriana
    Gherghiceanu, Florentina
    Bohiltea, Roxana Elena
    Stefan, Simona Diana
    Stoian, Anca Pantea
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2020, 20 (03) : 2387 - 2391
  • [22] Non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus in Greenland
    Gantzel, Rasmus Hvidbjerg
    Muhammad, Abdullah Ghassan Farik
    Hansen, Frederik Orm
    Rex, Karsten Fleischer
    Villadsen, Gerda Elisabeth
    Gronbaek, Henning
    Pedersen, Michael Lynge
    JOURNAL OF HEPATOLOGY, 2022, 77 : S418 - S419
  • [23] Impact of Non-Alcoholic Fatty Liver Disease on Metabolic Comorbidities in Type 2 Diabetes Mellitus
    Labenz, Christian
    Kostev, Karel
    Alqahtani, Saleh A.
    Galle, Peter R.
    Schattenberg, Joern M.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2022, 130 (03) : 172 - 177
  • [24] Common Pathogenetic Pathways of Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus
    Giannopoulos, Charalampos K.
    Tzima, Ioanna G.
    Tentolouris, Nikolaos K.
    Vasileiadis, Ioannis A.
    CURRENT DIABETES REVIEWS, 2023, 19 (09) : 96 - 114
  • [25] Novel antidiabetic medications for non-alcoholic fatty liver disease with type 2 diabetes mellitus
    Sumida, Yoshio
    Seko, Yuya
    Yoneda, Masashi
    HEPATOLOGY RESEARCH, 2017, 47 (04) : 266 - 280
  • [26] Cognitive Performance in Individuals with Non-Alcoholic Fatty Liver Disease and/or Type 2 Diabetes Mellitus
    Weinstein, Ali A.
    de Avila, Leyla
    Paik, James
    Golabi, Pegah
    Escheik, Carey
    Bush, Haley
    Raficq, Nila
    Gerber, Lynn
    Younossi, Zobair M.
    HEPATOLOGY, 2018, 68 : 1073A - 1073A
  • [27] Is it time for non-alcoholic fatty liver disease screening in patients with type 2 diabetes mellitus?
    Targher, Giovanni
    HEPATOBILIARY SURGERY AND NUTRITION, 2020, 9 (02) : 239 - 241
  • [28] Effects Of Endurance Exercise On Non-alcoholic Fatty Liver Disease And Type 2 Diabetes Mellitus
    Segovia, Benny
    Cosio-Lima, Ludmila
    Crawly, Amy
    Talcott, Tim
    Lee, Youngil
    MEDICINE & SCIENCE IN SPORTS & EXERCISE, 2023, 55 (09) : 465 - 465
  • [30] Non-alcoholic fatty liver disease and type 2 diabetes: An update
    Lee, Chi-H
    Lui, David T. W.
    Lam, Karen S. L.
    JOURNAL OF DIABETES INVESTIGATION, 2022, 13 (06) : 930 - 940